Published in J Immunol Methods on February 06, 2007
Toll-like receptor cascade and gene polymorphism in host-pathogen interaction in Lyme disease. J Inflamm Res (2016) 0.76
RASMOL: biomolecular graphics for all. Trends Biochem Sci (1995) 33.76
Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50
MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res (2004) 9.86
Lyme disease. N Engl J Med (2001) 7.29
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med (1996) 5.46
The emergence of Lyme disease. J Clin Invest (2004) 5.24
Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol (2000) 4.71
ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res (2004) 4.10
Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis (1993) 3.92
Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol (1999) 3.80
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68
IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res (2004) 3.14
Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun (1993) 3.04
Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med (2004) 3.02
Treatment of Lyme arthritis. Arthritis Rheum (1994) 2.27
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun (1993) 2.18
Elucidation of Lyme arthritis. Nat Rev Immunol (2004) 1.93
The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun (1999) 1.79
Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab. Proc Natl Acad Sci U S A (1997) 1.78
The inference of antigen selection on Ig genes. J Immunol (2000) 1.74
WAM: an improved algorithm for modelling antibodies on the WEB. Protein Eng (2000) 1.67
Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc Natl Acad Sci U S A (2000) 1.61
Modeling antibody hypervariable loops: a combined algorithm. Proc Natl Acad Sci U S A (1989) 1.50
Human immunoglobulin variable region gene analysis by single cell RT-PCR. J Immunol Methods (2000) 1.49
IMGT, The International ImMunoGeneTics Information System, http://imgt.cines.fr. Methods Mol Biol (2004) 1.48
Kabat Database and its applications: future directions. Nucleic Acids Res (2001) 1.45
Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun (1994) 1.45
Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies. Eur J Immunol (1987) 1.26
Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect Immun (2003) 1.13
Antibody discovery: phage display. Curr Opin Biotechnol (2002) 1.02
Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. J Mol Biol (2000) 1.01
Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. J Autoimmun (2001) 1.01
Of mice and men: hybridoma and recombinant antibodies. Immunol Today (2000) 1.00
The B cell repertoire of patients with rheumatoid arthritis. II. Increased frequencies of IgG+ and IgA+ B cells specific for mycobacterial heat-shock protein 60 or human type II collagen in synovial fluid and tissue. Arthritis Rheum (1997) 0.95
Host-pathogen interactions and the pathogenesis of murine Lyme disease. Curr Opin Rheumatol (2002) 0.95
Autoantibodies from synovial lesions in chronic, antibiotic treatment-resistant Lyme arthritis bind cytokeratin-10. J Immunol (2006) 0.94
Human naive B cells cultured with EL-4 T cells mimic a germinal center-related B cell stage before generating plasma cells. Concordant changes in Bcl-2 protein and messenger RNA levels. Eur J Immunol (1997) 0.93
Performance of the first protein docking server ClusPro in CAPRI rounds 3-5. Proteins (2005) 0.92
Development of autoimmunity in Lyme arthritis. Curr Opin Rheumatol (2002) 0.87
In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium. J Immunol (2005) 0.87
A new method for the analysis and production of monoclonal antibody fragments originating from single human B cells. J Immunol Methods (1997) 0.84
Cellular and molecular aspects of Lyme arthritis. Cell Mol Life Sci (2000) 0.81
Human monoclonal antibodies. Mol Cell Biochem (1984) 0.80
Molecular mimicry and Lyme arthritis. Curr Dir Autoimmun (2001) 0.80
Is it thee or me?--autoimmunity in Lyme disease. Nat Med (1999) 0.78
Combining EL4-B5-based B-cell stimulation and phage display technology for the successful isolation of human anti-Scl-70 autoantibody fragments. J Immunol Methods (2003) 0.77
Single-chain anti-DNA FV. Methods Mol Biol (1995) 0.76
A comparison of three methods for production of human hybridomas secreting autoantibodies. Hybridoma (1998) 0.76
Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology (2010) 2.75
Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescence. Cell Cycle (2009) 1.51
Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis. J Neurosci (2011) 1.23
Defective B cell responses in the absence of SH2D1A. Proc Natl Acad Sci U S A (2005) 1.21
Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect Immun (2003) 1.13
Phosphorylation of the pro-apoptotic protein Bim in lymphocytes is associated with protection from apoptosis. Mol Immunol (2003) 1.01
Age-associated decline in effective immune synapse formation of CD4(+) T cells is reversed by vitamin E supplementation. J Immunol (2007) 0.99
Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death. Eur J Immunol (2007) 0.98
Beta2 integrins control the severity of murine Lyme carditis. Infect Immun (2005) 0.97
Molecular pathogenesis of chronic lymphocytic leukemia. Curr Mol Med (2006) 0.96
Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J Rheumatol (2005) 0.96
Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol (2004) 0.96
Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J Immunol (2005) 0.95
Autoantibodies from synovial lesions in chronic, antibiotic treatment-resistant Lyme arthritis bind cytokeratin-10. J Immunol (2006) 0.94
Aggravated Lyme carditis in CD11a-/- and CD11c-/- mice. Infect Immun (2005) 0.92
Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J Immunol (2006) 0.92
HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol (2009) 0.90
Chemokines and Toll-like receptors in Lyme disease pathogenesis. Trends Mol Med (2005) 0.89
CD28 deficiency exacerbates joint inflammation upon Borrelia burgdorferi infection, resulting in the development of chronic Lyme arthritis. J Immunol (2007) 0.89
Lymphocyte quiescence factor Dpp2 is transcriptionally activated by KLF2 and TOB1. Mol Immunol (2008) 0.89
In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium. J Immunol (2005) 0.87
Development of autoimmunity in Lyme arthritis. Curr Opin Rheumatol (2002) 0.87
Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor. Bioorg Med Chem Lett (2006) 0.86
Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity. Endocrinology (2009) 0.85
HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis. Arthritis Rheum (2009) 0.85
An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proc Natl Acad Sci U S A (2004) 0.84
EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology (2008) 0.83
Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor. Br J Haematol (2005) 0.83
HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination. Arthritis Rheum (2009) 0.83
Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence Immunoassays. Adv Virol (2011) 0.82
B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy (2015) 0.81
Infectious arthritis and immune dysregulation: lessons from Lyme disease. Curr Opin Rheumatol (2010) 0.81
Vitamin E reverses impaired linker for activation of T cells activation in T cells from aged C57BL/6 mice. J Nutr (2009) 0.81
The MHC class I-related FcRn ameliorates murine Lyme arthritis. Int Immunol (2006) 0.80
Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment. Arthritis Rheum (2008) 0.80
Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia. Exp Hematol (2010) 0.79
Th17 differentiation is the default program for DPP2-deficient T-cell differentiation. Eur J Immunol (2011) 0.78
Murine Vbeta3+ and Vbeta7+ T cell subsets are specific targets for the HERV-K18 Env superantigen. J Immunol (2006) 0.78
Human endogenous retrovirus-K18 superantigen expression and human herpesvirus-6 and human herpesvirus-7 viral loads in chronic fatigue patients. Clin Infect Dis (2013) 0.77
Characterization of in vivo expanded OspA-specific human T-cell clones. Clin Immunol (2005) 0.77
Emergence of chronic Lyme arthritis: putting the breaks on CD28 costimulation. Immunopharmacol Immunotoxicol (2009) 0.76
Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists. Mol Immunol (2011) 0.76
Differential T-cell activation by B7-1 expression. Immunology (2003) 0.76
Biologically distinct conformations of Bcl-x can be resolved using 2D isoelectric focusing. Mol Immunol (2009) 0.75
Native and recombinant interleukin-2, two functionally distinct molecules. Mol Immunol (2003) 0.75
Assessment of specific T-cell activation by superantigens. Methods Mol Biol (2003) 0.75